Pharma stocks including Abbott India, Sun Pharma, Torrent Pharma, Cipla and Divi’s Laboratories are in focus after announcing FY26 dividends…
Nomura sees up to 26% upside in Cipla, Dr Reddy’s Lab, and Crompton Greaves—discover why these stocks are top picks…
Grasim to get Rs 3,970 crore from UltraTech dividend; Jefferies sees 15% upside—track Grasim’s moves for investment opportunities!
Cipla surges 8% despite 55% profit drop as brokerages turn bullish—explore if this rally signals a buying opportunity!
Dalal Street witnessed sharp stock-specific action as Cipla, Adani Enterprises, MTAR Technologies and Oil India rallied after earnings and deals,…
Sensex, Nifty today, May 14: Sensex jumps nearly 800 points, Nifty closes strong at 23,700; explore top gainers and market…
Cipla Q4 profit plunges 55% to Rs 555 crore; company announces Rs 13 dividend. Learn more about Cipla’s financial results!
Sensex, Nifty updates today, May 13: Markets rebound as Sensex surges over 500 points and Nifty climbs above 23,500; track…
Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
JM Financial warns of a widening gap between Nifty valuations and earnings as 66% of companies see EPS cuts. Here…
IT shares emerge as top laggards
Sensex and Nifty closed slightly lower amid broad sectoral weakness—see which stocks moved and track market trends now.
The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…
The Indian domestic pharmaceutical market grew to ₹2.46 lakh crore in FY26, fueled by a 13.6% jump in the cardiac…
Monday watchlist, April 05: Track Vedanta, Tata Steel, and top small-caps as technical trends signal possible short-term reversals—review market moves…
Emkay Global retains Buy on KPIL with a target of Rs 1,450, citing strong T&D growth drivers; discover if this…
India approves Rs 2.38 trillion defence deals, spotlighting BEL, HAL, L&T, and GRSE—track these stocks for future order wins!
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…